ARDX
NASDAQ · Biotechnology
Ardelyx Inc
$7.05
+0.07 (+1.00%)
Open$7.05
Previous Close$6.98
Day High$7.06
Day Low$6.98
52W High$8.40
52W Low$3.21
Volume—
Avg Volume5.29M
Market Cap1.75B
P/E Ratio—
EPS$-0.24
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+568.7% upside
Current
$7.05
$7.05
Target
$47.14
$47.14
$33.22
$47.14 avg
$55.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 420.36M | 211.87M | 556.78M |
| Net Income | -63,579,560 | -28,841,534 | -22,621,785 |
| Profit Margin | -15.1% | -14.4% | -4.1% |
| EBITDA | -38,680,053 | -18,521,194 | -31,484,723 |
| Free Cash Flow | — | — | -21,445,059 |
| Rev Growth | +98.4% | +98.4% | +16.2% |
| Debt/Equity | 1.21 | 1.21 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |